ABSTRACT
Sentinel lymph node (SLN) mapping and biopsy procedures have been used in gynecological malignities for some decades. Growing experience enables these procedures to get into clinical practice in endometrial, cervical, and vulvar carcinomas. For vaginal and ovarian cancers, more studies are needed. In this review, the evaluation of SLN procedures are handled through technical aspects and results of clinical studies.
References
1
Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
2
Martelli G, Boracchi P, De Palo M, et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg 2005; 242: 1-6, discussion 7-9.
3
Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-933.
4
Burke TW, Levenback C, Tornos C, et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996;62:169-173.
5
Cibula D, Ooonk MH, Abu Rustum NR. Sentinel lymph node biopsy in the management of gynecologic cancer. Curr Opin Obstet Gynecol 2015;27:66-72.
6
Sözen H, Özkan ZG. Jinekolojik malignitelerde sentinel lenf nodu uygulamaları. Nükleer Tıp Seminerleri 2017;3:140-150.
7
Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Canc Netw 2014;12:288-297.
8
NCCN Clinical Practice Guidelines in Oncology. Uterine Cancer. Version 1.2022. NCCN.org
9
Herrmann K, Nieweg OE, Povoski SP. Radioguided Surgery. 1st ed. Springer International Publishing Switzerland 2016:249-264.
10
Giammarile F, Bozkurt MF, Cibula D, et al. The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers. Eur J Nucl Med Mol Imaging 2014;41:1463-1477.
11
Ballester M, Dubernard G, Rouzier R, et al. Use of the sentinel node procedure to stage endometrial cancer. Ann Surg Oncol 2008;15:1523-1529.
12
Bats AS, Clément D, Larousserie F, et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J Surg Oncol 2008;97:141-145.
13
Barranger E, Delpech Y, Coutant C, et al. Laparoscopic sentinel node mapping using combined detection for endometrial cancer: a study of 33 cases – is it a promising technique? Am J Surg 2009;197:1-7.
14
Mais V, Peiretti M, Gargiulo T, et al. Intraoperative sentinel lymph node detection by vital dye through laparoscopy or laparotomy in early endometrial cancer. J Surg Oncol 2010;101:408-412.
15
Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP gudelines fort he management of patients with endometrial carcinoma. Gynecol Cancer 2021;31:12-39.
16
Rozenholc A, Samouelian V, Warkus T, et al. Green versus blue: randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer. Gynecol Oncol 2019;153:500-504.
17
Frumovitz M, Plante M, Lee PS, et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol 2018;19:1394-1403.
18
Pandit-Taskar N, Gemignani ML, Lyall A, et al. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol 2010;117:59-64.
19
How J, Gotlieb WH, Press JZ, et al. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. Gynecol Oncol 2015;137:436-442.
20
Kitchener H, Swart AMC, Qian Q, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-136.
21
Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707-1716.
22
NCCN Clinical Practice Guidelines in Oncology. Cervical Cancer. Version 1.2022. NCCN.org
23
Rob L, Strnad P, Robova H, et al. Study of lymphatic mapping and identification in early stage cervical cancer. Gynecol Oncol 2005;98:281-288.
24
Bats AS, Mathevet P, Buenerd A, et al. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol 2013;20:413-422.
25
Roy M, Bouchard-Fortier G, Popa I, et al. Value of sentinel node mapping in cancer of the cervix. Gynecol Oncol 2011;122:269-274.
26
Bader AA, Winter R, Haas J, et al. Where to look for the sentinel lymph node in cervical cancer. Am J Obstet Gynecol 2013;197:678.e1-7.
27
Cibula D, Pötter R, Planchamp F, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int J Gynecol Cancer 2018;28:641-655.
28
Buda A, Elisei F, Arosio M, et al. Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer. Int J Gynecol Cancer 2012;22:830-835.
29
Ruscito I, Gasparri ML, Braicu EI, et al. Sentinel node mapping in cervical and endometrial cancer: indocyanine green versus other conventional dyes—A meta-analysis. Ann Surg Oncol 2016;23:3749-3756.
30
Cibula D, Abu-Rustum NR, Dusek L, et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 2012;124:496-501.
31
Cibula D, Kocian R, Plaikner A, et al. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial. European Journal of Cancer 2020;137:69-80.
32
Mathevet P, Lecuru F, Uzan C, et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2). European Journal of Cancer 2021;148:307-315.
33
Van der Zee AG, Oonk MH, de Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;20:884-889.
34
Burger MP, Hollema H, Emanuels AG, et al. The importance of the groin node status for the survival of T1 ad T2 vulval carcinoma patients. Gynecol Oncol 1995;57:327-334.
35
NCCN Clinical Practice Guidelines in Oncology. Vulvar Cancer. Version 1.2022. NCCN.org
36
DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol 1979;133:825-832.
37
Carlson JW, Kauderer J, Hutson A, et al. GOG 244, the lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients. Gynecol Oncol 2018;149:6-7.
38
Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of nonsentinel- node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010;11:646-652.
39
Levenback CF, Ali S, Coleman R, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 2012;30:3786-3791.
40
Matheron HM, van den Berg NS, Brouwer OR, et al. Multimodal surgical guidance towards the sentinel node in vulvar cancer. Gynecol Oncol 2015;131:720-725.
41
Hutteman M, van der Vorst JR, Gaarenstroom KN, et al. Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer. Am J Obstet Gynecol. 2013;206:89.e1-5.
42
Crane LM, Themelis G, Arts HJ, et al. Intraoperative near-infrared fluorescent imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol 2013;120:291-295.
43
Schaafsma BE, Verbeek FPR, Peters AAW, et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomized comparison of lymphatic tracers BJOG 2013;120:758-764.
44
Carter JS, Levi SD Jr: Vulvar and vaginal cancer. Obstet Gynecol Clin North Am 2012;39:213-231.
45
Frumovitz M, Gaued IW, Jhingran A, et al. Lymphatic mapping of sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 2008;108:478-481.
46
Hertel H, Soergel P, Muecke J. Is there a place for sentinel technique in treatment of vaginal cancer? Feasibility, clinical experience, and results. Int J Gynecol Cancer 2013;23:1692-1698.
47
Kobayashi K, Raminez PT, Kim EE, et al: Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med 2009;34:859-861.
48
Kim R, Rose PG. Surgical staging of gynecologic malignancies: The role of laparoscopy and sentinel node technology. Surg Oncol Clin N Am 2005;14:267-288.
49
Pandi-Taskar N. Oncologic imaging in gynecologic malignancies. J Nucl Med 2005;46:1842-1850.
50
Achouri A, Huchon C, Bats AS, et al. Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol 2013;39:81-86.
51
Kleppe M, Brans B, Van Gorp T, et al. The detection of sentinel nodes in ovarian cancer: A feasibility study. J Nucl Med 2014;55:1799-1804.
52
Buda A, Passoni P, Corrado G, et al. Near-infrared fluorescence-guided sentinel node mapping of the ovary with indocyanine green in a minimally invasive setting: A feasible study. J Minim Invasive Gynecol 2017;24:165-170.
53
Kimmig R, Buderath P, Rusch P, et al. Early ovarian cancer surgery with indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, pelvic part). J Gynecol Oncol 2017;28:e68.
54
Lago V, Bello P, Montero B, et al. Clinical application of the sentinel lymph node technique in early ovarian cancer: A pilot study. Int J Gynecol Cancer 2019;29:377-381.
55
El-Ghobashy AE, Saidi SA. Sentinel lymph node sampling in gynecological cancers: Techniques and clinical applications. Eur J Surg Oncol 2009;35:675-685.